Skip to main content

1-20 of 147 results for subject:Databases

Legislation X
Access to Medical Treatments (Innovation) Bill 2015-16

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

More
Access to Medical Treatments (Innovation) Bill 2015-16 (147)

Subject

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

Type
Select Committee reports; Select Committee reports (Government responses); House of Lords papers; Parliamentary committees
Committee
Delegated Powers and Regulatory Reform Committee
Date
9 March 2016
Reference
HL 111 2015-16
House
House of Lords

We would not have had stents put in hearts, bypasses, ablations—

Member
Lord Patel (Crossbench)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 c558
House
House of Lords

Yes, we would not have had Marie Curie’s radiation treatment. One of my children is an oncologist, so I know what they do. The noble Lord is quite right: fortunately, such procedures do not have to go through this stringent process. Some argue that they should, but that would be...

Member
Lord Patel (Crossbench)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 c558
House
House of Lords

My Lords, I support the Bill and congratulate the noble Lord, Lord Saatchi, on introducing it in your Lordships’ House. I want to refer particularly to those parts of the Bill that relate to the use of off-patent drugs: Clause 1, which refers to promoting access to,

“the off-label use of...

Member
Lord Murphy of Torfaen (Labour)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc555-6
House
House of Lords

My Lords, I beg to move that this Bill be now read a second time. These days, the parliamentarians in another place are often an abused minority who receive very little praise. What they usually get is offhand criticism from people who question their motives and behaviour. However, to those...

Member
Lord Saatchi (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc548-552
House
House of Lords

My Lords, first, I congratulate the noble Lord, Lord Saatchi, on his indomitable determination to see something on the statute book concerning access to innovative medical treatments. I have been asked by the noble Baroness, Lady Gardner of Parkes, to say that she would have been here today supporting the...

Member
Baroness Masham of Ilton (Crossbench)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc549-554
House
House of Lords

My Lords, I echo the comments of my noble friend Lord Saatchi on the quality of the debate in the other place, which I followed very closely. I speak as a lay man and shall be brief, referring only to innovation. My interest in the Bill stems from several years...

Member
Lord Ryder of Wensum (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc554-5
House
House of Lords

My Lords, I am delighted to support this Bill and hope that it will have a swift passage through this House and become legislation. I congratulate the noble Lord, Lord Saatchi, on presenting it in great detail and in his usual style, and—given the difficulties his predecessor Bill had—on his...

Member
Lord Patel (Crossbench)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc556-8
House
House of Lords

Would many current surgical procedures have been authorised if they had had to go through the kind of clinical trial process that medicines do?

Member
Lord Hunt of Kings Heath (Labour)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 c558
House
House of Lords

Marie Curie.

Member
Lord Blencathra (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 c558
House
House of Lords

My Lords, I declare an interest in that I would benefit personally if some medical innovation or off-label drug helped my MS problem. I would probably also benefit financially, because I would save hundreds of pounds on all the various vitamin pills and potions that I scoff liberally in the...

Member
Lord Blencathra (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc558-562
House
House of Lords

My Lords, I, too, am delighted to support the Bill. I speak today, as many noble Lords do, as one touched by the tragedy of cancer. As some noble Lords may know, my sister died two years of mesothelioma. Recent data from the Office for National Statistics show that 43%...

Member
Lord Freyberg (Crossbench)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc562-5
House
House of Lords

My Lords, I thank the noble Lord for bringing the Bill to your Lordships’ House and I commend him for his perseverance and stamina as he sought to take it and the previous Bill through. I, too, pay tribute to the honourable Chris Heaton-Harris for taking the Bill through the...

Member
Lord Hunt of Kings Heath (Labour)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc563-6
House
House of Lords

My assumption is not based on when the Queen’s Speech would be or when the Commons rises. In the Commons, the days for Private Members’ Bills are announced at the start of the Session, and Friday 11 March has been announced as the last day. Even if the Commons ran...

Member
Lord Blencathra (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 c566
House
House of Lords

But on that basis, even if there were no Committee or Report stage, it would still be too late. Will the Minister join me in asking the usual channels whether we can find some time before

11 March to take this Bill through, even if the Government may need to...

Member
Lord Hunt of Kings Heath (Labour)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc566-7
House
House of Lords

My Lords, it has been a fascinating debate. I was not here when we have had debates about this Bill or the Bill that preceded it, so I am not as familiar with the arguments as many noble Lords are. However, it has been a very insightful and high-quality debate.

I...

Member
Lord Prior of Brampton (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc567-570
House
House of Lords

My Lords, before the noble Lord finishes, will he agree that the excuse of confidentiality can be a stifling block to innovation? Les Halpin was an example of openness. Surely patients and doctors should be sharing and working together. Therefore, they should have the information.

Member
Baroness Masham of Ilton (Crossbench)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 c569
House
House of Lords

My Lords, all my experience over the last 15 years is that openness and transparency are critical to get improvement and innovation into the NHS, but we have to accept that patient confidentiality is also extremely important. If we in any way compromise or give people reason to think that...

Member
Lord Prior of Brampton (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 c569
House
House of Lords

I appreciate that no Minister at the Dispatch Box would dare make any commitment about more time for a Bill or rescheduling, which is the complete province of the Chief Whips and Leaders on both sides, but will my noble friend the Minister make some representations to the usual channels...

Member
Lord Blencathra (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 c569
House
House of Lords

I was going to come to that point right at the end. The noble Lord, Lord Hunt, raised it as well. I give complete assurance that the Government will do everything they can to work with the noble Lord opposite and others to ensure that the Bill goes through. It...

Member
Lord Prior of Brampton (Conservative)
Type
Proceeding contributions
Date
26 February 2016
Reference
769 cc569-571
House
House of Lords